Inventor

DAVIES STEPHEN JOHN

GB20 patents

⚠️ This page may combine multiple inventors who share the name “DAVIES STEPHEN JOHN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

DAVIES STEPHEN JOHN

CHROMA THERAPEUTICS LTD

Enzyme inhibitors

IKK-beta serine-threonine protein kinase inhibitors

Tert-butyl N-[2-{4-[6-amino-5-(2,4-difluorobenzoyl)-2-oxopyridin-1(2H)-yl]-3,5-difluorophenyl}ethyl]-L-alaninate or a salt, hydrate or solvate thereof

Tert-butyl N-[2-{4-[6-amino-5-(2,4-difluorobenzoyl)-2-oxopyridin-1(2H)-yl]-3,5-difluorophenyl}ethyl]-L-alaninate or a salt,hydrate or solvate thereof

Enzyme inhibitors

2-aminopyrazine derivatives as CSF-1R kinase inhibitors

BRITISH BIOTECH PHARM

Antibacterial agents

Antibacterial agents

Antibacterial agents

Antibacterial agents

Antibacterial agents

DAVIDSON ALAN HORNSBY

Enzyme inhibitors

Quinoline and quinoxaline derivatives as inhibitors of kinase enzymatic activity

MOFFAT DAVID CHARLES FESTUS

Inhibitors of IKK-beta serine-threonine protein kinase

MYT EQUIPMENT INC

Exercise device for supporting weight from hand grips using straps

MOFFAT DAVID FESTUS CHARLES

Inhibitors of P38 map kinase

VERNALIS OXFORD LTD

Derivatives of hydroxamic acid as metalloproteinase inhibitors

GLAXOSMITHKLINE IP DEV LTD

Enzyme and receptor modulation using covalent conjugates of alpha,alpha-disubstituted glycine esters

MACROPHAGE PHARMA LTD

Tert-butyl N-[2-{4-[6-amino-5-(2,4-difluorobenzoyl)-2-oxopyridin-1(2H)-YL]-3,5-difluorophenyl}ethyl]-L-alaninate or a salt, hydrate or solvate thereof

VERNALIS R&D LTD

Oxa-and thiadiazoles and their use as metalloproteinase inhibitors